Guided Therapeutics (GTHP) Depreciation and Depletion (2014 - 2025)
Guided Therapeutics recorded quarterly Depreciation and Depletion of $3000.0 in Q4 2025, up 50.0% quarter-over-quarter from $2000.0 in Q3 2025, and up 50.0% year-over-year from $2000.0 in Q4 2024.
Guided Therapeutics' Depreciation and Depletion history runs 6 years deep, the most recent figure standing at $3000.0 for Q4 2025.
- In Q4 2025, Depreciation and Depletion rose 50.0% year-over-year to $3000.0; the TTM figure through Dec 2025 stood at $10000.0 (up 11.11% YoY), while the FY2025 annual figure was $10000.0, up 11.11% from the prior year.
- Depreciation and Depletion came in at $3000.0 for Q4 2025 at Guided Therapeutics, up from $2000.0 in the prior quarter.
- In the past five years, Depreciation and Depletion ranged from a high of $2.3 million in Q3 2023 to a low of $1000.0 in Q3 2022.
- A 4-year average of $167571.4 and a median of $2000.0 in 2023 frame the typical range for Depreciation and Depletion.
- Across the five-year window, Depreciation and Depletion jumped 231500.0% in 2023 and plunged 99.91% in 2024, its largest moves.
- Guided Therapeutics' Depreciation and Depletion stood at $3000.0 in 2022, then tumbled by 33.33% to $2000.0 in 2023, then changed by 0.0% to $2000.0 in 2024, then soared by 50.0% to $3000.0 in 2025.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $3000.0, $2000.0, and $3000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 308.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 29.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Sep 30, 2025 | 2,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Sep 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 2.32 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Mar 31, 2023 | 2,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Jun 30, 2015 | 72,000.00 |
| Jun 30, 2015 | 72,000.00 |
| Mar 31, 2015 | 72,000.00 |
| Mar 31, 2015 | 72,000.00 |
| Jun 30, 2014 | 118,000.00 |
| Jun 30, 2014 | 118,000.00 |
| Mar 31, 2014 | 117,000.00 |
| Mar 31, 2014 | 117,000.00 |